Log In
BCIQ
Print this Print this
 

NRL-2

  Manage Alerts
Collapse Summary General Information
Company Neurelis Inc.
DescriptionIntranasal formulation of lorazepam
Molecular Target GABA A receptor
Mechanism of ActionGABA A receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAnxiety
Indication DetailsTreat acute anxiety
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today